July 3, 2009
Pharmaceutical Curriculum Vitae, Works of Art or Dissertations?
ASCO meeting 2009: current blockbusters advance standard care in new indications
Serono’s Erbitux set to be first biologic treatment for mCRC in the UK
Please ‘SIGN IN’ or ‘Register’ with Detail-Direct.com first to access these resources. Access is only available to UK registered healthcare professionals

Chronic Pain
Learn more about ARCOXIA and the management of osteoarthritis, rheumatoid arthritis and gout.